Tag Archive for: Uplizna

The drug was being studied for the treatment of Immunoglobulin G4-related disease, which is characterized by periods of remission and unpredictable disease flares.

Amgen confirmed Monday it will acquire rare disease giant Horizon Therapeutics for $26.4 billion.

And then there were two. Janssen (Johnson & Johnson) is no longer in the running to acquire rare disease player Horizon Therapeutics, the company announced Saturday.